Drug Profile
Research programme: diacylglycerol transferase-1 inhibitors - Madrigal Pharmaceuticals
Alternative Names: DGAT1 inhibitors - Madrigal Pharmaceuticals; RO-5131723Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Roche
- Developer Madrigal Pharmaceuticals; Roche
- Class Carboxylic acids
- Mechanism of Action Diacylglycerol O acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity; Type 2 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Obesity in USA (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in USA
- 26 Mar 2012 Preclinical trials in Obesity in USA (PO)